0002047647-26-000002.txt : 20260706 0002047647-26-000002.hdr.sgml : 20260706 20260706111249 ACCESSION NUMBER: 0002047647-26-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260706 DATE AS OF CHANGE: 20260706 EFFECTIVENESS DATE: 20260706 FILER: COMPANY DATA: COMPANY CONFORMED NAME: 65 Therapeutics, Inc. CENTRAL INDEX KEY: 0002047647 ORGANIZATION NAME: EIN: 994832896 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-531309 FILM NUMBER: 261154794 BUSINESS ADDRESS: STREET 1: 399 REVOLUTION DRIVE CITY: SOMERVILLE STATE: MA ZIP: 02145 BUSINESS PHONE: 617-784-9147 MAIL ADDRESS: STREET 1: 399 REVOLUTION DRIVE CITY: SOMERVILLE STATE: MA ZIP: 02145 D/A 1 primary_doc.xml X0708 D/A LIVE 0002047647 65 Therapeutics, Inc. 399 REVOLUTION DRIVE SOMERVILLE MA MASSACHUSETTS 02145 617-784-9147 DELAWARE None None Corporation true 2024 Julius Knowles c/o 65 Therapeutics, Inc. 399 Revolution Drive Somerville MA MASSACHUSETTS 02145 Executive Officer Director Murthy Chavali c/o 65 Therapeutics, Inc. 399 Revolution Drive Somerville MA MASSACHUSETTS 02145 Director Pharmaceuticals Decline to Disclose 06b true 0002047647-24-000001 2024-11-21 false true false 0 6700000 6700000 0 false 2 0 0 0 false 65 Therapeutics, Inc. /s/ Julius Knowles Julius Knowles President 2026-07-01